Accolade, Inc. (ACCD)

Accolade Market Cap

Accolade has a market cap or net worth of $607.65 million as of April 26, 2024. Its market cap has decreased by -44.38% in one year.

• Market Cap: 607.65M
• Enterprise Value: 623.98M
• 1-Year Change: -44.38%
• Ranking: #2675
• Category: Small-Cap
• Stock Price: $7.85

Market Cap Chart

Since July 2, 2020, Accolade's market cap has decreased from $1.40B to $607.65M, a decrease of -56.47%. That is a compound annual growth rate of -19.58%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2024	711.40M	-2.23%
Apr 24, 2024	727.60M	0.53%
Apr 23, 2024	723.80M	1.53%
Apr 22, 2024	712.90M	0.88%
Apr 19, 2024	706.70M	-0.44%
Apr 18, 2024	709.80M	5.41%
Apr 17, 2024	673.40M	3.57%
Apr 16, 2024	650.20M	-2.11%
Apr 15, 2024	664.20M	4.01%
Apr 12, 2024	638.60M	-4.96%
Apr 11, 2024	671.90M	-3.02%
Apr 10, 2024	692.80M	-6.77%
Apr 9, 2024	743.10M	3.34%
Apr 8, 2024	719.10M	1.08%
Apr 5, 2024	711.40M	-0.64%
Apr 4, 2024	716.00M	-1.17%
Apr 3, 2024	724.50M	-2.50%
Apr 2, 2024	743.10M	-5.23%
Apr 1, 2024	784.10M	-3.34%
Mar 28, 2024	811.20M	4.90%
Mar 27, 2024	773.30M	0.30%
Mar 26, 2024	771.00M	2.79%
Mar 25, 2024	750.10M	2.11%
Mar 22, 2024	734.60M	-2.66%
Mar 21, 2024	754.70M	-0.81%

View and export this data all the way back to 2020. Sign Up Today.

Related Stocks

Company	Market Cap
Nurix Therapeutics	733.16M
Pharming Group	723.47M
CARGO Therapeutics	719.56M
Pliant Therapeutics	715.64M
OrthoPediatrics	712.16M
Autolus Therapeutics	710.33M
Evolus	704.76M
Arcturus Therapeutics Holdings	704.37M